4//SEC Filing
CATALYST PHARMACEUTICAL PARTNERS, INC. 4
Accession 0001161697-14-000518
$CPRXCIK 0001369568operating
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:34 PM ET
Size
8.7 KB
Accession
0001161697-14-000518
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2014-10-17$0.90/sh+125,000$112,500→ 142,294 total - Tax Payment
Common stock, par value $0.001 per share
2014-10-17−45,363→ 96,931 total - Exercise/Conversion
Options to purchase common stock
2014-10-17−125,000→ 297,500 totalExercise: $0.90Exp: 2014-10-20→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Holder exercised 125,000 options at $0.90 per share on a cashless basis and was issued 79,637 shares based on the October 17, 2014 closing price of $2.48 per share.
- [F2]The option was granted on October 20, 2009 and vested in three equal annual installments.
Documents
Issuer
CATALYST PHARMACEUTICAL PARTNERS, INC.
CIK 0001369568
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369568
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:34 PM ET
- Size
- 8.7 KB